01/19/2015

Analytical Methods for biomarkers Anti-IIa, Anti-Xa and TPFI

Anapharm Biotech, the peptide and protein chemistry division of Anapharm Europe, has completed method development of biomarkers Anti-IIa, Anti-Xa and TPFI in human plasma by chromogenic assays and ELISA, respectively. The determination of these biomarkers are relevant for the performance of clinical trials with Low Molecular Weight Heparins.

MORE NEWS

27/02/2025 16:40

Peptides Series: Understanding Therapeutic Peptides

Therapeutic peptides are transforming modern medicine thanks to their unique advantages over traditional drug therapies. Their molecular structure and biological properties allow them to achieve effects like natural molecules in the body, enabling targeted action with fewer risks of off-target effects.

READ MORE
16/01/2025 10:47

The visit of the Mayor of Barcelona, Jaume Collboni, to Anapharm Bioanalytics

Last Friday, January 10th 2025, we had the honor of welcoming the Mayor of Barcelona, Jaume Collboni, to our facilities. His visit was a special opportunity for us to showcase the work we do at Anapharm Bioanalytics and to reaffirm our commitment to innovation in the field of bioanalysis.

READ MORE
09/12/2024 15:38

Overcoming Matrix Effects in the Analysis of Lipophilic Compounds

At the 10th EBF Young Scientist Symposium, we highlighted the complexities of analysing Fucoxanthin derivatives and demonstrated how innovative approaches, such as 2D Chromatography, can overcome these obstacles.

READ MORE